iBio
IBIO
#10074
Rank
C$37.27 M
Marketcap
C$1.66
Share price
-6.25%
Change (1 day)
-54.35%
Change (1 year)

iBio (IBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : C$11.47 Million

According to iBio's latest financial reports the company's total liabilities are C$11.47 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

iBio - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30C$10.13 M-70.36%
2023-06-30C$34.18 M-26.09%
2022-06-30C$46.24 M-2.82%
2021-06-30C$47.58 M-6.72%
2020-06-30C$51.01 M38.54%
2019-06-30C$36.82 M4.03%
2018-06-30C$35.39 M0.57%
2017-06-30C$35.19 M-1.43%
2016-06-30C$35.7 M2165.9%
2015-06-30C$1.57 M273.86%
2014-06-30C$0.42 M-90.65%
2013-06-30C$4.5 M23.07%
2012-06-30C$3.66 M-46.79%
2011-06-30C$6.88 M68.63%
2010-06-30C$4.08 M555.03%
2009-06-30C$0.62 M-93.73%
2008-06-30C$9.93 M15.68%
2007-06-30C$8.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
C$36.47 M 217.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.21 B 10,477.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 1,367,016.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$0.29 B 2,503.99%๐Ÿ‡บ๐Ÿ‡ธ USA